No change in number of shares owned, just to reflect % as CYTK issued additional shares last year. The nice thing is that when analysts review Amgen SEC filings the stock ownership position in CYTK appears at the top of the pile. Nice.
Those are the same number of shares bought in 2009 @ 9.50 when this POS was trading at those levels back then. It´s an amazing thing to figure out why after almost four years and OM now in mid stage trials and at this dust levels they have not bought ONE single additional share. Why the foick not?... they could even get the snake oil Blums invention for ALS free and some cash in hand. Why in farts sake not buy one more?
Why AMGN has not bought more shares is obvious: the initial purchase was under a legal document . Any further purchases would have to be under an amended document. The proof in the pudding is that Amgen is following a well worn path: advance to late trials and then buy the company.
Looks like 2009 trade levels were not close to 9.50...it would have been before that. Understand you do not trust the guy, me either but could the early purchase just be evidence thay are a stakeholder...no more, no less.
Why the low trade volume? Even in spite of news that should have been taken as positive. Did some research on the presenter, he is the real thing.